SCHEMBL62168

SCHEMBL62168

[C]#CC#CCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL183702 0.87
SCHEMBL8936338 0.82
SCHEMBL302044 0.76
SCHEMBL183352 0.73
SCHEMBL183001 0.69
SCHEMBL1894280 0.66
SCHEMBL7109 0.66
SCHEMBL2088202 0.66 HMGCR (0.50)
SCHEMBL2085382 0.66 HMGCR (0.50)
SCHEMBL3625740 0.66 HMGCR (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2009 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050171078-A1 Novel azacyclic ethynyl derivatives NEUROSEARCH (DK) 2005-08-04 US claimed
EP-1506205-A2 NOVEL AZACYCLIC ETHYNYL DERIVATIVES NEUROSEARCH A/S (DK) 2005-02-16 EP claimed
WO-2003094830-A2 NOVEL AZACYCLIC ETHYNYL DERIVATIVES NEUROSEARCH A/S (DK) 2003-11-20 WO claimed
EP-0905118-B1 Unsaturated 6-tert-butyl-1,1-dimethylindane derivates substituted in the 4-position and their use in human and veterinary medicine as well as in cosmetics GALDERMA RES & DEV (FR) 2001-08-16 EP claimed
EP-0905118-A1 Unsaturated 6-tert-butyl-1,1-dimethylindane derivates substituted in the 4-position and their use in human and veterinary medicine as well as in cosmetics Galderma Research & Development, S.N.C. (FR) 1999-03-31 EP claimed
US-12043688-B2 Nickel catalysts with two alkali ions for homopolymerization and copolymerization UNIVERSITY OF HOUSTON SYSTEM (US) 2024-07-23 US disclosed
US-12042479-B2 Use of topical formulations of cannabinoids in the treatment of epidermolysis bullosa and related connective tissue disorders INMED PHARMACEUTICALS INC. 2024-07-23 US disclosed
US-12043689-B2 Nickel catalysts with single metal cations for homopolymerization and copolymerization UNIVERSITY OF HOUSTON SYSTEM (US) 2024-07-23 US disclosed
US-20240239751-A1 PROCESSES FOR PREPARING AG-10, ITS INTERMEDIATES, AND SALTS THEREOF BRIDGEBIO GENE THERAPY RESEARCH, INC. 2024-07-18 US disclosed
US-20240239807-A1 SARS-COV2 MAIN PROTEASE INHIBITORS GILEAD SCIENCES, INC. 2024-07-18 US disclosed
US-20240238427-A1 METHODS OF TREATING AN EYE DISORDER KODIAK SCIENCES INC. 2024-07-18 US disclosed
CN-118344348-A Heterocyclic substituted quinazoline and preparation method and application thereof 苏州泽璟生物制药股份有限公司 2024-07-16 CN disclosed
US-4971994-A INSECTICIDES, MITICIDES CIBA-GEIGY CORPORATION (US) 1990-11-20 US disclosed
US-4908383-A Pesticides CIBA-GEIGY CORPORATION (US) 1990-03-13 US disclosed
US-4855449-A Prostacyclin (PGI2) analogues SHIONOGI & CO., LTD. (JP) 1989-08-08 US disclosed
US-4820836-A ANTICOAGULANTS, ANTIULCER AGENTS SHIONOGI & CO., LTD. (JP) 1989-04-11 US disclosed
EP-0276823-A2 14,15-Substituted lanosterols and their use as hypocholesterolemic agents THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1988-08-03 EP disclosed
EP-0240890-A2 Prostacyclin (PGI2) analogues SHIONOGI & CO., LTD. (JP) 1987-10-14 EP disclosed
EP-0177353-A2 Thiazolidinedione derivatives, their production and use Takeda Chemical Industries, Ltd. (JP) 1986-04-09 EP disclosed
US-4119627-A Process for the manufacture of 6β,7-methylene-3-oxo-4-ene steroids CIBA-GEIGY CORPORATION (US) 1978-10-10 US disclosed